Rafferty Asset Management, LLC Heron Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

  • $26.8 Billion
  • Q2 2024

A detailed history of Rafferty Asset Management, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 257,560 shares of HRTX stock, worth $491,939. This represents 0.0% of its overall portfolio holdings.

Number of Shares
257,560
Holding current value
$491,939
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$2.32 - $3.86 $597,539 - $994,181
257,560 New
257,560 $901,000
Q3 2022

Nov 14, 2022
SELL
$2.66 - $5.37 $406,134 - $819,902
-152,682 Reduced 20.22%
602,451 $2.54 Million
Q2 2022

Aug 12, 2022
SELL
$2.3 - $6.29 $452,994 - $1.24 Million
-196,954 Reduced 20.69%
755,133 $2.11 Million
Q1 2022

May 13, 2022
BUY
$4.63 - $9.94 $1.81 Million - $3.88 Million
390,810 Added 69.63%
952,087 $5.45 Million
Q4 2021

Feb 10, 2022
BUY
$8.35 - $12.6 $2.45 Million - $3.7 Million
293,809 Added 109.85%
561,277 $5.12 Million
Q3 2021

Nov 10, 2021
BUY
$10.13 - $15.0 $993,601 - $1.47 Million
98,085 Added 57.91%
267,468 $2.86 Million
Q2 2021

Aug 10, 2021
SELL
$13.27 - $18.48 $362,390 - $504,670
-27,309 Reduced 13.88%
169,383 $2.63 Million
Q1 2021

May 10, 2021
BUY
$14.49 - $20.72 $2.36 Million - $3.37 Million
162,820 Added 480.69%
196,692 $3.19 Million
Q4 2020

Feb 10, 2021
SELL
$14.61 - $22.14 $1.1 Million - $1.66 Million
-75,112 Reduced 68.92%
33,872 $717,000
Q3 2020

Nov 13, 2020
BUY
$13.67 - $17.77 $992,195 - $1.29 Million
72,582 Added 199.39%
108,984 $1.62 Million
Q2 2020

Aug 07, 2020
BUY
$10.89 - $21.47 $282,617 - $557,189
25,952 Added 248.34%
36,402 $535,000
Q1 2020

May 15, 2020
SELL
$10.23 - $24.56 $931,236 - $2.24 Million
-91,030 Reduced 89.7%
10,450 $123,000
Q4 2019

Feb 10, 2020
SELL
$17.42 - $26.61 $297,620 - $454,631
-17,085 Reduced 14.41%
101,480 $2.39 Million
Q3 2019

Nov 14, 2019
SELL
$16.36 - $21.39 $1.43 Million - $1.88 Million
-87,689 Reduced 42.52%
118,565 $2.19 Million
Q2 2019

Aug 09, 2019
BUY
$16.93 - $26.22 $1.32 Million - $2.04 Million
77,812 Added 60.58%
206,254 $3.83 Million
Q1 2019

May 15, 2019
BUY
$23.15 - $28.34 $2.97 Million - $3.64 Million
128,442 New
128,442 $3.14 Million

Others Institutions Holding HRTX

# of Institutions
193
Shares Held
129M
Call Options Held
94.7K
Put Options Held
148K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $227M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email